Investigation of the Efficiency of Radial Extracorporeal Shock Wave Therapy at Different Pulses i… (NCT06321276) | Clinical Trial Compass
CompletedNot Applicable
Investigation of the Efficiency of Radial Extracorporeal Shock Wave Therapy at Different Pulses in Carpal Tunnel Syndrome
Turkey (Türkiye)98 participantsStarted 2023-11-01
Plain-language summary
Different parameters have been used in studies investigating the efficacy of extracorporeal shock wave therapy in the treatment of carpal tunnel syndrome. Although extracorporeal shock wave therapy has been shown to have a positive effect on carpal tunnel syndrome, there is no consensus on which pulse rate is more effective. Therefore, in this study, the efficacy of extracorporeal shock wave therapy applied at different pulse rates in the treatment of carpal tunnel syndrome will be examined.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female patients aged 18-65 years with carpal tunnel syndrome diagnosed clinically and by EMG
* Patients who can correctly understand what is stated in the patient information form and who can cooperate
* Patients who consent to participate in the study according to the informed consent form will be included in the study.
Exclusion Criteria:
* Cervical radiculopathy
* Polyneuropathy
* Brachial plexopathy
* Use of systemic corticosteroids or local corticosteroid injections
* History of fracture and trauma in the forearm and wrist on the treated side
* Inflammatory rheumatic disease
* Pregnant and lactating patients
* Systemic diseases such as renal failure, peptic ulcer, DM, hypothyroidism, coagulation disorder
* Patients undergoing carpal tunnel syndrome surgery
* People with pacemakers
* Thoracic outlet syndrome
* Tenar atrophy, severe carpal tunnel syndrome
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual analogue scale (VAS)
Timeframe: 0. week , 4. week , 12. week
2
Boston Carpal Tunnel Syndrome Questionnaire
Timeframe: 0. week, 4. week , 12. week
Trial details
NCT IDNCT06321276
SponsorAhi Evran University Education and Research Hospital